English
简体中文
Total: £ 56.28
Published Date: 2025-08-07 | Pages: 77 | Tables: 79 | Medical Care
The global In-Silico Drug Discovery market size was US$ 2489 million in 2024 and is forecast to a readjusted size of US$ 5410 million by 2031 with a CAGR of 11.9% during the forecast period 2025-2031.
In silico also known as computer-aided drug design is a process by which the drug is design or discovered by using computational methods. Drug discovery process is carried out to identify new drug molecules that can attach to a specific target. This method of identifying drugs is based on computation and the entire process is considered linear and consecutive. Various factors make in-silico drug discovery method more productive and a wise approach in comparison to earlier drug discovery methods used for the drug development process. In-silico drug design can play a significant role in all stages of drug development – from the initial lead designing to final stage clinical development.
The main In-Silico Drug Discovery players include Charles River, Certara USA, Inc., Evotec, etc. The top three In-Silico Drug Discovery players account for approximately 36% of the total global market. In terms of type, Consultancy as a Service is the largest segment, with a share about 41%. And in terms of Application, the largest application is Contract Research Organization, followed by Pharmaceutical Industry.
The global In-Silico Drug Discovery market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Charles River
Certara USA, Inc.
Evotec
Dassault System (Biovia)
Albany Molecular Research Inc. (AMRI)
Selvita
Schrödinger, Inc.
GVK BIO
OpenEye Scientific Software
Chemical Computing Group (CCG)
By Type: (Dominant Segment vs High-Margin Innovation)
Software as a Service (Cloud)
Consultancy as a Service
Software
By Application: (Core Demand Driver vs Emerging Opportunity)
Contract Research Organization
Pharmaceutical Industry
Academic and Research Institutes
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Charles River in Europe)
- Emerging Product Trends: Software as a Service (Cloud) adoption vs. Consultancy as a Service premiumization
- Demand-Side Dynamics: Contract Research Organization growth in China vs. Pharmaceutical Industry potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of In-Silico Drug Discovery market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Consultancy as a Service in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Pharmaceutical Industry in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the In-Silico Drug Discovery value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Software as a Service (Cloud)
1.2.3 Consultancy as a Service
1.2.4 Software
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Contract Research Organization
1.3.3 Pharmaceutical Industry
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Silico Drug Discovery Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global In-Silico Drug Discovery Revenue Market Share by Region (2020-2025)
2.4 Global In-Silico Drug Discovery Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America In-Silico Drug Discovery Market Size and Prospective (2020-2031)
2.5.2 Europe In-Silico Drug Discovery Market Size and Prospective (2020-2031)
2.5.3 Asia-Pacific In-Silico Drug Discovery Market Size and Prospective (2020-2031)
2.5.4 Latin America In-Silico Drug Discovery Market Size and Prospective (2020-2031)
2.5.5 Middle East & Africa In-Silico Drug Discovery Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global In-Silico Drug Discovery Historic Market Size by Type (2020-2025)
3.2 Global In-Silico Drug Discovery Forecasted Market Size by Type (2026-2031)
3.3 Different Types In-Silico Drug Discovery Representative Players
4 Breakdown Data by Application
4.1 Global In-Silico Drug Discovery Historic Market Size by Application (2020-2025)
4.2 Global In-Silico Drug Discovery Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in In-Silico Drug Discovery Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top In-Silico Drug Discovery Players by Revenue (2020-2025)
5.1.2 Global In-Silico Drug Discovery Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by In-Silico Drug Discovery Revenue
5.4 Global In-Silico Drug Discovery Market Concentration Analysis
5.4.1 Global In-Silico Drug Discovery Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by In-Silico Drug Discovery Revenue in 2024
5.5 Global Key Players of In-Silico Drug Discovery Head office and Area Served
5.6 Global Key Players of In-Silico Drug Discovery, Product and Application
5.7 Global Key Players of In-Silico Drug Discovery, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America In-Silico Drug Discovery Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America In-Silico Drug Discovery Market Size by Type (2020-2025)
6.1.2.2 North America In-Silico Drug Discovery Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America In-Silico Drug Discovery Market Size by Application (2020-2025)
6.1.3.2 North America In-Silico Drug Discovery Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe In-Silico Drug Discovery Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe In-Silico Drug Discovery Market Size by Type (2020-2025)
6.2.2.2 Europe In-Silico Drug Discovery Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe In-Silico Drug Discovery Market Size by Application (2020-2025)
6.2.3.2 Europe In-Silico Drug Discovery Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Asia-Pacific Market: Players, Segments and Downstream
6.3.1 Asia-Pacific In-Silico Drug Discovery Revenue by Company (2020-2025)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific In-Silico Drug Discovery Market Size by Type (2020-2025)
6.3.2.2 Asia-Pacific In-Silico Drug Discovery Market Share by Type (2020-2025)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific In-Silico Drug Discovery Market Size by Application (2020-2025)
6.3.3.2 Asia-Pacific In-Silico Drug Discovery Market Share by Application (2020-2025)
6.3.4 Asia-Pacific Market Trend and Opportunities
6.4 Latin America Market: Players, Segments and Downstream
6.4.1 Latin America In-Silico Drug Discovery Revenue by Company (2020-2025)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America In-Silico Drug Discovery Market Size by Type (2020-2025)
6.4.2.2 Latin America In-Silico Drug Discovery Market Share by Type (2020-2025)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America In-Silico Drug Discovery Market Size by Application (2020-2025)
6.4.3.2 Latin America In-Silico Drug Discovery Market Share by Application (2020-2025)
6.4.4 Latin America Market Trend and Opportunities
6.5 Middle East & Africa Market: Players, Segments and Downstream
6.5.1 Middle East & Africa In-Silico Drug Discovery Revenue by Company (2020-2025)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa In-Silico Drug Discovery Market Size by Type (2020-2025)
6.5.2.2 Middle East & Africa In-Silico Drug Discovery Market Share by Type (2020-2025)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa In-Silico Drug Discovery Market Size by Application (2020-2025)
6.5.3.2 Middle East & Africa In-Silico Drug Discovery Market Share by Application (2020-2025)
6.5.4 Middle East & Africa Market Trend and Opportunities
7 Key Players Profiles
7.1 Charles River
7.1.1 Charles River Company Details
7.1.2 Charles River Business Overview
7.1.3 Charles River In-Silico Drug Discovery Introduction
7.1.4 Charles River Revenue in In-Silico Drug Discovery Business (2020-2025)
7.1.5 Charles River Recent Development
7.2 Certara USA, Inc.
7.2.1 Certara USA, Inc. Company Details
7.2.2 Certara USA, Inc. Business Overview
7.2.3 Certara USA, Inc. In-Silico Drug Discovery Introduction
7.2.4 Certara USA, Inc. Revenue in In-Silico Drug Discovery Business (2020-2025)
7.2.5 Certara USA, Inc. Recent Development
7.3 Evotec
7.3.1 Evotec Company Details
7.3.2 Evotec Business Overview
7.3.3 Evotec In-Silico Drug Discovery Introduction
7.3.4 Evotec Revenue in In-Silico Drug Discovery Business (2020-2025)
7.3.5 Evotec Recent Development
7.4 Dassault System (Biovia)
7.4.1 Dassault System (Biovia) Company Details
7.4.2 Dassault System (Biovia) Business Overview
7.4.3 Dassault System (Biovia) In-Silico Drug Discovery Introduction
7.4.4 Dassault System (Biovia) Revenue in In-Silico Drug Discovery Business (2020-2025)
7.4.5 Dassault System (Biovia) Recent Development
7.5 Albany Molecular Research Inc. (AMRI)
7.5.1 Albany Molecular Research Inc. (AMRI) Company Details
7.5.2 Albany Molecular Research Inc. (AMRI) Business Overview
7.5.3 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Introduction
7.5.4 Albany Molecular Research Inc. (AMRI) Revenue in In-Silico Drug Discovery Business (2020-2025)
7.5.5 Albany Molecular Research Inc. (AMRI) Recent Development
7.6 Selvita
7.6.1 Selvita Company Details
7.6.2 Selvita Business Overview
7.6.3 Selvita In-Silico Drug Discovery Introduction
7.6.4 Selvita Revenue in In-Silico Drug Discovery Business (2020-2025)
7.6.5 Selvita Recent Development
7.7 Schrödinger, Inc.
7.7.1 Schrödinger, Inc. Company Details
7.7.2 Schrödinger, Inc. Business Overview
7.7.3 Schrödinger, Inc. In-Silico Drug Discovery Introduction
7.7.4 Schrödinger, Inc. Revenue in In-Silico Drug Discovery Business (2020-2025)
7.7.5 Schrödinger, Inc. Recent Development
7.8 GVK BIO
7.8.1 GVK BIO Company Details
7.8.2 GVK BIO Business Overview
7.8.3 GVK BIO In-Silico Drug Discovery Introduction
7.8.4 GVK BIO Revenue in In-Silico Drug Discovery Business (2020-2025)
7.8.5 GVK BIO Recent Development
7.9 OpenEye Scientific Software
7.9.1 OpenEye Scientific Software Company Details
7.9.2 OpenEye Scientific Software Business Overview
7.9.3 OpenEye Scientific Software In-Silico Drug Discovery Introduction
7.9.4 OpenEye Scientific Software Revenue in In-Silico Drug Discovery Business (2020-2025)
7.9.5 OpenEye Scientific Software Recent Development
7.10 Chemical Computing Group (CCG)
7.10.1 Chemical Computing Group (CCG) Company Details
7.10.2 Chemical Computing Group (CCG) Business Overview
7.10.3 Chemical Computing Group (CCG) In-Silico Drug Discovery Introduction
7.10.4 Chemical Computing Group (CCG) Revenue in In-Silico Drug Discovery Business (2020-2025)
7.10.5 Chemical Computing Group (CCG) Recent Development
8 In-Silico Drug Discovery Market Dynamics
8.1 In-Silico Drug Discovery Industry Trends
8.2 In-Silico Drug Discovery Market Drivers
8.3 In-Silico Drug Discovery Market Challenges
8.4 In-Silico Drug Discovery Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global In-Silico Drug Discovery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global In-Silico Drug Discovery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market In-Silico Drug Discovery Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global In-Silico Drug Discovery Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global In-Silico Drug Discovery Revenue Share by Region (2020-2025)
Table 6. Global In-Silico Drug Discovery Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global In-Silico Drug Discovery Revenue Share Forecast by Region (2026-2031)
Table 8. Global In-Silico Drug Discovery Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global In-Silico Drug Discovery Revenue Market Share by Type (2020-2025)
Table 10. Global In-Silico Drug Discovery Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global In-Silico Drug Discovery Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global In-Silico Drug Discovery Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global In-Silico Drug Discovery Revenue Market Share by Application (2020-2025)
Table 15. Global In-Silico Drug Discovery Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global In-Silico Drug Discovery Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in In-Silico Drug Discovery Application
Table 18. Global In-Silico Drug Discovery Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global In-Silico Drug Discovery Market Share by Players (2020-2025)
Table 20. Global Top In-Silico Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Silico Drug Discovery as of 2024)
Table 21. Ranking of Global Top In-Silico Drug Discovery Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by In-Silico Drug Discovery Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of In-Silico Drug Discovery, Headquarters and Area Served
Table 24. Global Key Players of In-Silico Drug Discovery, Product and Application
Table 25. Global Key Players of In-Silico Drug Discovery, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America In-Silico Drug Discovery Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America In-Silico Drug Discovery Revenue Market Share by Company (2020-2025)
Table 29. North America In-Silico Drug Discovery Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America In-Silico Drug Discovery Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe In-Silico Drug Discovery Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe In-Silico Drug Discovery Revenue Market Share by Company (2020-2025)
Table 33. Europe In-Silico Drug Discovery Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe In-Silico Drug Discovery Market Size by Application (2020-2025) & (US$ Million)
Table 35. Asia-Pacific In-Silico Drug Discovery Revenue by Company (2020-2025) & (US$ Million)
Table 36. Asia-Pacific In-Silico Drug Discovery Revenue Market Share by Company (2020-2025)
Table 37. Asia-Pacific In-Silico Drug Discovery Market Size by Type (2020-2025) & (US$ Million)
Table 38. Asia-Pacific In-Silico Drug Discovery Market Size by Application (2020-2025) & (US$ Million)
Table 39. Latin America In-Silico Drug Discovery Revenue by Company (2020-2025) & (US$ Million)
Table 40. Latin America In-Silico Drug Discovery Revenue Market Share by Company (2020-2025)
Table 41. Latin America In-Silico Drug Discovery Market Size by Type (2020-2025) & (US$ Million)
Table 42. Latin America In-Silico Drug Discovery Market Size by Application (2020-2025) & (US$ Million)
Table 43. Middle East & Africa In-Silico Drug Discovery Revenue by Company (2020-2025) & (US$ Million)
Table 44. Middle East & Africa In-Silico Drug Discovery Revenue Market Share by Company (2020-2025)
Table 45. Middle East & Africa In-Silico Drug Discovery Market Size by Type (2020-2025) & (US$ Million)
Table 46. Middle East & Africa In-Silico Drug Discovery Market Size by Application (2020-2025) & (US$ Million)
Table 47. Charles River Company Details
Table 48. Charles River Business Overview
Table 49. Charles River In-Silico Drug Discovery Product
Table 50. Charles River Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 51. Charles River Recent Development
Table 52. Certara USA, Inc. Company Details
Table 53. Certara USA, Inc. Business Overview
Table 54. Certara USA, Inc. In-Silico Drug Discovery Product
Table 55. Certara USA, Inc. Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 56. Certara USA, Inc. Recent Development
Table 57. Evotec Company Details
Table 58. Evotec Business Overview
Table 59. Evotec In-Silico Drug Discovery Product
Table 60. Evotec Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 61. Evotec Recent Development
Table 62. Dassault System (Biovia) Company Details
Table 63. Dassault System (Biovia) Business Overview
Table 64. Dassault System (Biovia) In-Silico Drug Discovery Product
Table 65. Dassault System (Biovia) Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 66. Dassault System (Biovia) Recent Development
Table 67. Albany Molecular Research Inc. (AMRI) Company Details
Table 68. Albany Molecular Research Inc. (AMRI) Business Overview
Table 69. Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Product
Table 70. Albany Molecular Research Inc. (AMRI) Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 71. Albany Molecular Research Inc. (AMRI) Recent Development
Table 72. Selvita Company Details
Table 73. Selvita Business Overview
Table 74. Selvita In-Silico Drug Discovery Product
Table 75. Selvita Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 76. Selvita Recent Development
Table 77. Schrödinger, Inc. Company Details
Table 78. Schrödinger, Inc. Business Overview
Table 79. Schrödinger, Inc. In-Silico Drug Discovery Product
Table 80. Schrödinger, Inc. Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 81. Schrödinger, Inc. Recent Development
Table 82. GVK BIO Company Details
Table 83. GVK BIO Business Overview
Table 84. GVK BIO In-Silico Drug Discovery Product
Table 85. GVK BIO Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 86. GVK BIO Recent Development
Table 87. OpenEye Scientific Software Company Details
Table 88. OpenEye Scientific Software Business Overview
Table 89. OpenEye Scientific Software In-Silico Drug Discovery Product
Table 90. OpenEye Scientific Software Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 91. OpenEye Scientific Software Recent Development
Table 92. Chemical Computing Group (CCG) Company Details
Table 93. Chemical Computing Group (CCG) Business Overview
Table 94. Chemical Computing Group (CCG) In-Silico Drug Discovery Product
Table 95. Chemical Computing Group (CCG) Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 96. Chemical Computing Group (CCG) Recent Development
Table 97. In-Silico Drug Discovery Market Trends
Table 98. In-Silico Drug Discovery Market Drivers
Table 99. In-Silico Drug Discovery Market Challenges
Table 100. In-Silico Drug Discovery Market Restraints
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. In-Silico Drug Discovery Product Picture
Figure 2. Global In-Silico Drug Discovery Market Share by Type: 2024 VS 2031
Figure 3. Software as a Service (Cloud) Features
Figure 4. Consultancy as a Service Features
Figure 5. Software Features
Figure 6. Global In-Silico Drug Discovery Market Share by Application: 2024 VS 2031
Figure 7. Contract Research Organization
Figure 8. Pharmaceutical Industry
Figure 9. Academic and Research Institutes
Figure 10. Others
Figure 11. In-Silico Drug Discovery Report Years Considered
Figure 12. Global In-Silico Drug Discovery Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global In-Silico Drug Discovery Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global In-Silico Drug Discovery Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America In-Silico Drug Discovery Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe In-Silico Drug Discovery Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Asia-Pacific In-Silico Drug Discovery Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Latin America In-Silico Drug Discovery Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Middle East & Africa In-Silico Drug Discovery Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Global In-Silico Drug Discovery Market Share by Players in 2024
Figure 21. Global Top In-Silico Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Silico Drug Discovery as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by In-Silico Drug Discovery Revenue in 2024
Figure 23. North America In-Silico Drug Discovery Market Share by Type (2020-2025)
Figure 24. North America In-Silico Drug Discovery Market Share by Application (2020-2025)
Figure 25. Europe In-Silico Drug Discovery Market Share by Type (2020-2025)
Figure 26. Europe In-Silico Drug Discovery Market Share by Application (2020-2025)
Figure 27. Asia-Pacific In-Silico Drug Discovery Market Share by Type (2020-2025)
Figure 28. Asia-Pacific In-Silico Drug Discovery Market Share by Application (2020-2025)
Figure 29. Latin America In-Silico Drug Discovery Market Share by Type (2020-2025)
Figure 30. Latin America In-Silico Drug Discovery Market Share by Application (2020-2025)
Figure 31. Middle East & Africa In-Silico Drug Discovery Market Share by Type (2020-2025)
Figure 32. Middle East & Africa In-Silico Drug Discovery Market Share by Application (2020-2025)
Figure 33. Charles River Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 34. Certara USA, Inc. Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 35. Evotec Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 36. Dassault System (Biovia) Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 37. Albany Molecular Research Inc. (AMRI) Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 38. Selvita Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 39. Schrödinger, Inc. Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 40. GVK BIO Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 41. OpenEye Scientific Software Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 42. Chemical Computing Group (CCG) Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
